The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Cancer Policy

House Energy & Commerce hearing focuses on America’s leadership in biomedical research, examines FDA role

White House regulatory priorities include “aggressive” HHS agenda

HHS cancels fourth USPSTF meeting in a row

FDA halts public release of Complete Response Letters, following citizen petition

Cancer patients with Medicare Advantage have access to fewer providers than Medicare patients, cross-sectional study finds

CMS proposes end-of-life counseling provision, echoing ACA “death panels” controversy

Clinical Roundup

Lenalidomide maintenance may end after two years for patients with MM, phase III trial finds

Digital check-ins improve outcomes for cancer patients, Alliance trial finds

Virtual smoking cessation program for patients with cancer doubles quitting rate in community oncology settings

Jemperli achieves sustained clinical complete responses in dMMR/MSI-H locally advanced rectal cancer, phase II study finds

Ris-Rez improves overall survival in SCLC, phase III trial finds

Experimental KRAS vaccine generates immune response against pancreatic cancer in people at high risk, phase I study finds

In The Clinic
Trials & Tribulations

Saving Western Kenya’s pediatric blood cancer patients
How flow cytometry is changing the diagnostic landscape

Trials & Tribulations
FreeTrials & Tribulations
FreeTrials & Tribulations

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account